References
1-Chatrath, N., et al., The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure. ESC heart failure, 2020. 7 (6): p. 4443-4447.
2 Varghese, G.M., et al., Clinical management of COVID-19. The Indian journal of medical research, 2020. 151 (5): p. 401-410.
3-Cheruiyot, I., et al., Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review. Annals of vascular surgery, 2021.70 : p. 273-281.
4-McBane, R.D., 2nd, Arterial Thrombosis and Coronavirus Disease 2019. Mayo Clinic proceedings, 2021. 96 (2): p. 274-276.
5-Burn, E., et al., Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis, 2022.
6-Gold, D.D., R. Kurd, and S. Einav, Don’t forget arterial thrombosis in patients with COVID-19: A case series. Thrombosis Update, 2021.5 : p. 100065.
7-Levi, M., et al., Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol, 2020. 7 (6): p. e438-e440.
8-Abou-Ismail, M.Y., et al., The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis research, 2020.194 : p. 101-115.
9-Kubánková, M., et al., Physical phenotype of blood cells is altered in COVID-19. Biophysical journal, 2021. 120 (14): p. 2838-2847.
10-Whyte, C.S., et al., Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost, 2020. 18 (7): p. 1548-1555.
11-Roberts, K.A., et al., Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction. Frontiers in cardiovascular medicine, 2020. 7 : p. 598400-598400.
12-Whitson, B.A., et al., Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients. Ann Thorac Surg, 2014. 97 (6): p. 2097-103.
13-Fatullayev, J., et al., Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Foreseen is a Danger Avoided. Medical science monitor basic research, 2015. 21 : p. 141-144.
14-Dang, G., et al., Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. Asaio j, 2017. 63 (4): p. 373-385.
15-Upshaw, J.N., et al., Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis. Asaio j, 2016. 62 (1): p. 33-9.
16-Gyoten, T., et al., Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices. J Artif Organs, 2021. 24 (2): p. 173-181.
17-Gyoten, T., et al., Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2021. 24 (2): p. 173-181.
18-Tchantchaleishvili, V., et al., Evaluation and treatment of pump thrombosis and hemolysis. Annals of cardiothoracic surgery, 2014.3 (5): p. 490-495.
19-Jennings, D.L. and P.A. Weeks, Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management. Pharmacotherapy, 2015. 35 (1): p. 79-98.
20-Goldstein, D.J., et al., Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant, 2013.32 (7): p. 667-70.
21-Webber, B.T., A.L. Panos, and Y.F. Rodriguez-Blanco, Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation. Annals of cardiac anaesthesia, 2016. 19 (1): p. 192-196.
22-Nair, N., et al., Thrombolytics in VAD management - A single-center experience. International journal of cardiology. Heart & vasculature, 2016. 11 : p. 49-54.
23-Alkhunaizi MA, Ali B. Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban. Am J Case Rep. 2021 Dec 9;22:e934787. doi: 10.12659/AJCR.934787. PMID: 34880201; PMCID: PMC8669518.
24-Pendyal A, Chien CV, Mudd JO, Gelow JM. Minimally Invasive LVAD Deactivation in a 65-Year-Old Man with Recurrent Pump Thrombosis and Left Ventricular Recovery. Tex Heart Inst J. 2017 Feb 1;44(1):70-72. doi: 10.14503/THIJ-16-5787. PMID: 28265218; PMCID: PMC5317366.
25-Hubbert, L. , Forssell, C. , Baranowski, J. , Lindgren, B. , Holm, J. & Ahn, H. (2017). Endovascular Stenting of a LVAD Outflow Graft Thrombosis. ASAIO Journal, 63 (1), e3-e5. doi: 10.1097/MAT.0000000000000371.
26-Rajapreyar, I. , Acharya, D. , Tallaj, J. , Hornbuckle, L. , Sharpton, J. , Joly, J. & Pamboukian, S. (2019). Left Ventricular Assist Device Thrombosis—Amiodarone-Induced Hyperthyroidism: Causal Link?. ASAIO Journal, 65 (2), e18-e20. doi: 10.1097/MAT.0000000000000773.
27-Rajapreyar, I. , Acharya, D. , Tallaj, J. , Hornbuckle, L. , Sharpton, J. , Joly, J. & Pamboukian, S. (2019). Left Ventricular Assist Device Thrombosis—Amiodarone-Induced Hyperthyroidism: Causal Link?. ASAIO Journal, 65 (2), e18-e20. doi: 10.1097/MAT.0000000000000773.
28-Dobner S, Gräni C, Hugi-Mayr B, Mihalj M, Rhyner D, Wieser M, Martinelli M, Hunziker L, Reineke D. Pump thrombosis and dynamic outflow graft compression: complications in left ventricular assist device therapy. ESC Heart Fail. 2021 Apr;8(2):1631-1636. doi: 10.1002/ehf2.13244. Epub 2021 Feb 10. PMID: 33566444; PMCID: PMC8006604.
29-Sivathasan C, Tan TE, Sim D, Kerk KL. ”Burnt out” dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis. Clin Case Rep. 2015 Jun;3(6):376-8. doi: 10.1002/ccr3.237. Epub 2015 Apr 9. PMID: 26185632; PMCID: PMC4498846.
30-Bunge, Jeroen J. H.*,†; den Uil, Corstiaan A.*,†; Constantinescu, Alina C.*; Budde, Ricardo P. J.‡; Maat, Alexander P. W. M.§; Caliskan, Kadir* Acute Pump Thrombosis in the Early Postoperative Period After HeartMate 3 Implantation, ASAIO Journal: September/October 2019 - Volume 65 - Issue 7 - p e72-e74 doi: 10.1097/MAT.0000000000000932
31-Frick WH, et al. Unusual Case of Pump Thrombosis in LVAD Patient with COVID-19. The VAD Journal. 2020; 6(2):e2020622.https://doi.org/ 10.11589/vad/e2020622.
32-Jarrett SA, et al. Left Ventricular Assist Device Thrombosis Treated with Intravenous Tissue Plasminogen Activator in a patient with COVID-19 Infection. The VAD Journal. 2021; 7(1):e2021716. https://doi.org/10.11589/vad/e 2021716
33-Hodges K, Mubashir M, Insler J, et al. Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device. J Card Surg. 2020;35(11):3202-3204. doi:10.1111/jocs.14937.
34- Maharaj V, Steiner M, Boyle B, Kazmirczak F, Markowitz J, Alexy T, Shaffer A, John R, Martin CM, Cogswell R, Kamdar F. Rapidly Progressive Left Ventricular Assist Device Outflow Graft Thrombosis Associated With COVID-19 Infection. Circ Heart Fail. 2021 Dec;14(12):e008334. doi: 10.1161/CIRCHEARTFAILURE.121.008334. Epub 2021 Nov 15. PMID: 34775782.
35-Zakrzewski J, Coyle L, Aicher T, Chickerillo K, Gallagher C, Kuper K, Sciamanna C, Chau VQ, Tatooles A. Impact of COVID-19 on Patients Supported with a Left Ventricular Assist Device. ASAIO J. 2021 Nov 1;67(11):1189-1195. doi: 10.1097/MAT.0000000000001578. PMID: 34475334; PMCID: PMC8555883.
36- Birati, Edo Y et al. “Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.” Circulation. Heart failure vol. 14,4 (2021): e007957. doi:10.1161/CIRCHEARTFAILURE.120.007957